BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
search help

Documents 1-25 out of 109 found
  Current Search:  thio: 1016, thiosulfate: 135  

100%
PDF
http://www.plantsci.cam.ac.uk/Balk/papers/Muhlenhoff2004.pdf
Mutations in proteins involved in Fe/ S cluster maturation other than IscS can affect the thiolation pattern of tRNA in bacteria, indicating that for some tRNA species thio- modification crucially involves Fe/ S proteins (39, 40).
coli strain HMS174 (DE3) harboring plasmid pET15b- NFS1 was grown at 30 °C in LB medium supplemented with 50 M pyridoxal phosphate and 1 mM...

Matching: thio thiosulfate Find similar documents More document info

100%
PDF
http://www.plantsci.cam.ac.uk/Balk/papers/Muhlenhoff2004.pdf page 2


Matching: thio thiosulfate Find similar documents More document info

56%
PDF
February 21, 2001
(281) 367- 1983 25025 I- 45 North (800) 327- 7817 The Woodlands, Texas 77380 (800) 424- 9300 CHEMTREC (24- Hour Emergency Response) (800) 222- 1222 POISON CONTROL SUBSTANCE: PayZone 750 SYNONYMS: Sodium Thiosulfate, pentahydrate, Thosulfuric acid, Sodium salt CHEMICAL FAMILY: Inorganic salt MSDS CREATION DATE: 28 MAY 98 MSDS REVISION DATE: 13 OCT 03 SECTION 2: COMPOSITION,...

author: Paula Savage
Matching: thiosulfate Find similar documents More document info

56%
PDF
February 21, 2001 page 3


author: Paula Savage
Matching: thiosulfate Find similar documents More document info

56%
PDF
February 21, 2001 page 1


author: Paula Savage
Matching: thiosulfate Find similar documents More document info

56%
HTML
Wyle Laboratories :: Utility Services Seismic and EQ Test Services
Seismic and Accident Testing Capabilities Wyle is the one-stop shop for all your environmental qualification testing needs including seismic, LOCA and HELB testing.
Thermocouples and electronic temperature controllers are used to maintain the specified thermal aging temperature.
The following table provides a sample listing of the capabilities of these units.
Test chamber...
Matching: thiosulfate Find similar documents More document info
56%
PDF
ProductCatalog
Pr o d u c t s 2 0 0 3/ 2004 PHARMA GROUP LIMITED Bioniche Life Sciences Inc.
CORPORATE PROFILE PHARMA GROUP LIMITED CONTENTS Acetylcysteine (Parvolex®)_ _ _ _ _ 2 Amiodarone _ _ _ _ _ _ _ _ _ _ _ 2 Ascorbic Acid _ _ _ _ _ _ _ _ _ _ _ 2 Ascorbic Acid (BetaC®) _ _ _ _ _ _ 2 B- Complex 100 Injection _ _ _ _ _ _ 3 Bacteriostatic Sodium Chloride _ _ _ 3 Carbachol Tablets _ _...

author: Kathy Vandermey
duplicates:
http://www.bioniche.com/pdf/ProductCatalog.pdf
Matching: Find similar documents More document info

56%
PDF
ProductCatalog page 9


author: Kathy Vandermey
duplicates:
http://www.bioniche.com/pdf/ProductCatalog.pdf
Matching: Find similar documents More document info

56%
PDF
ProductCatalog page 3


author: Kathy Vandermey
duplicates:
http://www.bioniche.com/pdf/ProductCatalog.pdf
Matching: Find similar documents More document info

56%
PDF
http://www.merck.com/product/usa/pi_circulars/m/mustargen_trituration/mustargen_pi.pdf
7417934 TRITURATION OF MUSTARGEN ® (MECHLORETHAMINE HCl for INJECTION) WARNINGS MUSTARGEN * (Mechlorethamine HCl) should be administered only under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents.
For a 1/ 6 molar solution of sodium thiosulfate, use 4.14 g of sodium thiosulfate per 100 mL of Sterile Water for Injection or 2.64 g...

Matching: thiosulfate Find similar documents More document info

56%
PDF
http://www.merck.com/product/usa/pi_circulars/m/mustargen_trituration/mustargen_pi.pdf page 1


Matching: thiosulfate Find similar documents More document info

56%
HTML
Adherex Technologies Inc.
- -* ASCO 2004 Annual Meeting Poster Session * ADHEREX RELEASES INITIAL EXHERIN™ CLINICAL DATA AT ASCO - Preliminary safety profile satisfactory with hints of biological activity NEW ORLEANS, LA, JUNE 7, 2004 – Adherex Technologies Inc
- Results demonstrated that Exherin™ was well tolerated in cancer patients in all five tested doses (ranging from 50 to 281 mg/m 2 )...
Matching: thiosulfate Find similar documents More document info
56%
PDF
Hydrating slides for fixatives containing mercury.xls
1.1 2.1 Potassium iodide Iodine Crystals Sodium Thiosulphate Distilled water 4.1 Principle: 4.2 4.3 Iodine crystals will go into solution more effectively when dissolved in a high concentration solution of Potassium iodide.
Add 2gm of potassium iodide.
Add 95mL of distilled water, bringing the total volume to 100mL.
5% Sodium Thiosulfate 4.0 Action/ Decision- making...

author: Michele Shackleton
Matching: thiosulfate Find similar documents More document info

56%
PDF
Hydrating slides for fixatives containing mercury.xls page 1


author: Michele Shackleton
Matching: thiosulfate Find similar documents More document info

56%
HTML
Adherex Technologies Inc.
- ADHEREX COMPLETES FINANCINGS FOR 12.4 MILLION - - New institutional investors complement further investment by- major shareholders RESEARCH TRIANGLE PARK, NORTH CAROLINA and OTTAWA, ONTARIO, May 20, 2004 - Adherex Technologies Inc
and OrbiMed Advisors as well as new institutional investors.-- In connection with the offerings, the Company issued 23,347,170 units at a purchase...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
- PETER KARMANOS, Jr
(TSX: AHX), a biopharmaceutical company with a broad portfolio of products under development, today announced the appointment of Peter Karmanos, Jr., to the Company’s Board of Directors
Peter Karmanos, Jr
- What more could you ask for in a board member?” said Dr
- In 1973, Mr
Karmanos is also deeply committed to philanthropy
He was...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
- ADHEREX TECHNOLOGIES REPORTS THIRD QUARTER RESULTS - RESEARCH TRIANGLE PARK, NORTH CAROLINA AND OTTAWA, ONTARIO, MAY 2 6 , 2004 – Adherex Technologies Inc
The Company plans to fully occupy its space in North Carolina by August 2004
Food and Drug Administration (FDA) granted Adherex orphan drug designation for the use of Sodium Thiosulfate (STS) as a chemoprotectant...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
- ADHEREX ANNOUNCES NEW CHIEF FINANCIAL OFFICER - RESEARCH TRIANGLE PARK, NORTH CAROLINA and OTTAWA, CANADA, April 26, 2004 – Adherex Technologies Inc
William P
He has extensive experience in raising capital, strategic alliances, Securities and Exchange Commission reporting, investor relations, mergers and acquisitions and treasury management.” ---- “Adherex has...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
- Adherex A nnounces Merger with Oxiquant N ew entity will focus on developing pipeline of anti-cancer compounds - OTTAWA, ONTARIO, October 2, 2002 – Adherex Technologies Inc
The four compounds include Exherin™, Adherex’s drug candidate that targets N-cadherin to destroy cancer blood vessels, and three products from Oxiquant: Sodium Thiosulfate (STS), a...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
- Adherex - Oxiquant Merger Completed Company has four anti-cancer compounds ready for clinical development- Ottawa, ON (November 21, 2002) – Adherex Technologies (TSX: AHX), a drug discovery and development company with an exclusive focus on cancer, today announced its merger with Oxiquant Inc
Oxiquant has three products currently in the clinical stage of development: Sodium...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
- New CEO Announced for Adherex World-renowned oncologist and breast cancer specialist to lead oncology company OTTAWA, ONTARIO, February 19, 2003 – Adherex Technologies Inc
“As Adherex becomes specialized in cancer treatments, I felt it was important to have someone who is totally immersed in the field lead the Company through to commercialization and Bill is certainly...
Matching: thiosulfate Find similar documents More document info
56%
HTML
Adherex Technologies Inc.
STS Children undergoing platinum-based chemotherapy for malignancies have a very high incidence of disabling hearing impairment
- In young children who have received platinum-based therapy, clinical, behavioral and psychological studies have demonstrated impairment of language acquisition with learning disability and cognitive dysfunction, and in older children, both educational...
Matching: thiosulfate Find similar documents More document info
56%
PDF
Microsoft Word - 18-235-1.doc page 6


author: axn9300
Matching: thiosulfate Find similar documents More document info

56%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...

Matching: thiosulfate Find similar documents More document info
56%
HTML
AllChem Performance Products Products List
AllChem Home Page Overview Divisions Industrial Chemicals Group Performance Products Contacts Products Directions: Gainesville, Florida Directions: Corsicana, Texas Petroleum Chemicals Group AllChem Industries, B.V
Credit Department Support Employee Access - Search - - Home : Performance Products AllChem Performance Products Algaecides Copper/ Poly Quat & Quat Alum - Aluminum...
author: Alex Olcese, Michelle McKeough, Robin Fowler
Matching: thiosulfate Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.